About US
Contact us
-
AlphaRx regains all rights to Indaflex from Cypress BioscienceAlphaRx, Inc. (OTCBB: ALRX) today announced that it has entered into an agreement with Cypress Bioscience (Nasdaq: CYPB), under which AlphaRx is regaining all rights to Indaflex(TM) from Cypress Bio2010/6/30
-
Alimera submits Iluvien NDA for DME to FDAAlimeraSciences,Inc.,(Nasdaq:ALIM),("Alimera"),abiopharmaceuticalcompanythatspecializesintheresearch,developmentandcommercializationofprescriptionophthalmicpharmaceuticals,hassubmittedaNewDr2010/6/30
-
Prospect Medical Holdings added to Russell 2000 IndexProspect Medical Holdings, Inc. (NASDAQ: PZZ) ("Prospect" or the "Company") today announced that it has been added to the list of public companies that comprise the Russell 2000® Index. In addit2010/6/30
-
Japan's MHLW grants full marketing authorization to REVLIMIDCelgene International Sàrl (NASDAQ: CELG) announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for use in com2010/6/28
-
Multistage Nanovector System Provides Sustained Delivery of siRNA Cancer Therapeutic in MiceNew research by scientists at The University of Texas Health Science Center at Houston (UTHealth) and The University of Texas M.D. Anderson Cancer Center could make it easier for patients to use a f2010/6/28
-
Even more metal substitution: BASF enters the long glass-fiber-reinforced polyamide marketWherever the most demanding technical requirements must be satisfied – in the automotive and machinery industries but also in the household appliance and leisure sectors – designers have often had t2010/6/28
-
CMC Postapproval Manufacturing Changes Reportable in Annual Reports20100625(3).rar2010/6/25
-
Lupus Nephritis Caused By Systemic Lupus Erythematosus — Developing Medical Products for Treatment20100625(2).rar source: FDA2010/6/25
-
Systemic Lupus Erythematosus — Developing Medical Products for Treatment20100625(1).rar source: FDA2010/6/25
-
World Pharma Trials Asia 2010World Pharma Trials Asia is the only Asia-focused event in China in 2010, where the World’s Top Pharmas, biotechs, CROs, and regulators convene to provide the most comprehensive knowledge into the bes2010/6/24